Review
Transcriptional regulators in mammary gland development and cancer

https://doi.org/10.1016/S1357-2725(03)00030-XGet rights and content

Abstract

The mammary gland represents a remarkable developmental system for the study of genetic programs underlying proliferation, differentiation and inductive tissue interactions. Mammary gland ontogeny occurs predominantly in the adult and involves a complex cycle of morphogenesis, with the continuous production, differentiation and apoptosis of mammary epithelial cells occurring with each pregnancy. Perturbations in pathways controlling any of these processes may lead to neoplasia. Substantial progress has been made in defining signaling pathways important for mammopoiesis, in particular those that mediate the effects of peptide and steroid hormones. However, much less is known about the transcriptional regulators that dictate cell specificity, proliferation and differentiation within the mammary gland. This review will discuss recent insights into the transcriptional networks important for mammary gland development and consider how deregulation of specific transcription factors contributes to the pathogenesis of breast cancer.

Introduction

A central question in developmental biology is the nature of the transcriptional circuitry that controls cell-fate determination and differentiation in a given organ or tissue. Transcription factors have been shown to have critical roles in numerous cellular systems, using targeted gene deletion together with gain-of-function studies. For example, MyoD, SCL, NeuroD, and Nkx2.5 have essential roles in muscle, hemopoietic, neuronal and heart development, respectively (Biben, Palmer, Elliott, & Harvey, 1997; Massari & Murre, 2000; Weintraub et al., 1991). Although some transcriptional regulators are restricted to specific lineages, most are expressed in multiple lineages and in several different organs. Within breast tissue, few cell-restricted transcription factors have been identified. While the estrogen and progesterone steroid hormone receptors display restricted expression profiles, the majority of regulators are also found in several tissues outside of this organ. It therefore appears likely that these transcription factors serve more than one function through their combinatorial association with distinct proteins in different cell types (Table 1).

Over the past few years, significant new insights have been made in our understanding of transcription factors and cofactors that guide development in the mammary gland. This review will highlight key nuclear regulatory proteins, many of which have been established to have critical roles in the mammary gland through their targeted deletion. Some of these transcription factors, upon deregulation, have been implicated in breast oncogenesis. We will discuss potential targets and mechanisms by which these factors may perturb normal breast epithelial cell development.

Section snippets

Development of the mammary gland

Development of the mammary gland occurs in distinct stages, initiating in the embryo but occurring primarily in the peripubertal animal. Both systemic hormones and the mammary stroma are critical for mammopoiesis. The rudimentary mammary gland first emerges in the embryo around day 10, evident as five pairs of placodes. By day 15, these have formed epithelial buds surrounded by mesenchymal cell layers (termed the primary mammary mesenchyme). Further development of the buds into ductal

LEF1 and epithelial–mesenchymal signaling in the embryo

LEF1 (lymphocyte enhancer factor 1) and the homeobox genes Msx1 and Msx2 (see below), play important roles in the development of the mammary gland primordia within the embryo. Abundant LEF1 RNA is visible in the mammary bud at E11.0 (van Genderen et al., 1994). Expression subsequently switches to the surrounding mammary mesenchymal cells. Within the adult mammary gland, LEF1 expression is very low. Targeted deletion of LEF1 in mice leads to an arrest in mammary organogenesis at a very early

Homeobox genes in mammary gland development and neoplasia

Over the past two decades homeobox genes have emerged as key regulators of developmental decisions. They play a direct role in cell-fate specification and maintenance of cell identity. Given their essential roles in the formation of several organs, including the CNS and skeleton, it seemed likely that they would participate in controlling one or more aspects of mammary gland development. The hallmark of this family is a helix-turn-helix DNA-binding domain, which mediates binding to a TAAT

Steroid hormone receptors and adult mammary gland development

Mammary gland development in the pubertal and reproductive phases is dependent on systemic hormones. Both estrogen and progesterone are required for ductal epithelial outgrowth and secretory function in the mammary gland (Imagawa et al., 1994). The regression of ducts and alveolar structures that occurs following removal of the ovaries can be rescued by exogenous estrogen or progesterone. Specific roles for the estrogen and progesterone receptors (ER and PR) and their coactivators have been

Stat3 and Stat5 in mammopoiesis

Prolactin is essential for expansion and differentiation of the mammary lobuloalveolar epithelium (Topper & Freeman, 1980). Targeted disruption of the prolactin receptor (PRLR), Janus-2 kinase (Jak2) and the transcription factor Stat5 has highlighted the importance of the prolactin pathway for mammopoiesis in vivo. Binding of prolactin to its cognate receptor triggers dimerisation and results in the recruitment and activation of Jak2. Activated Jak2 then phosphorylates the receptor and signal

Helix-loop-helix (HLH) genes in mammary development

The HLH class of transcription factors play critical roles in cell-fate determination and differentiation in numerous developmental systems. Id proteins act as dominant negative regulators of these DNA-binding transcription factors (Benezra, Davis, Lockshon, Turner, & Weintraub, 1990). The Id family comprises three members, each of which harbors an HLH motif that mediates dimerisation, but lacks the adjacent DNA-binding motif. Both Id1 and Id2 have roles within the mammary gland. Constitutive

c-myc

The proto-oncogene c-myc encodes a transcription factor that has a central role in regulating cell proliferation, and under stress conditions, triggering apoptosis (reviewed in Cole & McMahon, 1999; Dang, 1999). The c-myc protein contains a basic-helix-loop-helix/leucine zipper domain that mediates dimerisation with its partner Max, and has the ability to drive cells through G1/S transition. myc-max heterodimers apparently regulate gene activity through chromatin remodeling. The c-myc promoter

Conclusion

Transcription factors play an essential role in mammary gland development. The vast majority of these factors are also widely expressed in tissues outside of the mammary gland. The specific function of these regulatory proteins in mammary gland morphogenesis is likely to reflect the presence of cell-restricted cofactors and combinatorial action with other proteins. Recent work has revealed that many of these transcription factors are important for programming lobuloalveolar expansion and

Acknowledgements

Owing to space constraints, it has not been possible to cite all relevant publications. We thank Peter Maltezos for preparation of the figures, and Drs. S. Gerondakis and E. Thompson for helpful comments on the manuscript. The authors are supported by the Victorian Breast Cancer Research Consortium Inc. (Australia) and the Bone Marrow Research Laboratories, Royal Melbourne Hospital.

References (106)

  • J.K. Richer et al.

    Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells

    Journal of Biological Chemistry

    (2002)
  • E.Y. Sum et al.

    The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity

    Journal of Biological Chemistry

    (2002)
  • S. Teglund et al.

    Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses

    Cell

    (1998)
  • S.L. Anzick et al.

    AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

    Science

    (1997)
  • S. Bautista et al.

    In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity

    Clinical Cancer Research

    (1998)
  • E.M. Berns et al.

    c-myc amplification is a better prognostic factor than Her-2/neu amplification in primary breast cancer

    Cancer Research

    (1992)
  • C. Biben et al.

    Homeobox genes and heart development

    Cold Spring Harbour Symposium of Quantitative Biology

    (1997)
  • T. Bowman et al.

    Stats in oncogenesis

    Oncogene

    (2000)
  • C. Brisken et al.

    A paracrine role for the epithelial progesterone receptor in mammary gland development

    Proceedings of the National Academy of Sciences of United States of America

    (1998)
  • C. Brisken et al.

    Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling

    Genes Development

    (2000)
  • M.F. Buckley et al.

    Expression and amplification of cyclin genes in human breast cancer

    Oncogene

    (1993)
  • A. Care et al.

    Transduction of the SkBr3 breast carcinoma cell line with the Hoxb7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence

    Oncogene

    (1998)
  • C.H. Chang et al.

    ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis

    Oncogene

    (1997)
  • R.S. Chapman et al.

    Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3

    Genes Development

    (1999)
  • F. Chen et al.

    Paralogous mouse Hox genes, Hoxa9, Hoxb9, and Hoxd9, function together to control development of the mammary gland in response to pregnancy

    Proceedings of the National Academy of Sciences of United States of America

    (1999)
  • R.B. Clarke et al.

    Dissociation between steroid receptor expression and cell proliferation in the human breast

    Cancer Research

    (1997)
  • M.D. Cole et al.

    The myc oncoprotein: a critical evaluation of transactivation and target gene regulation

    Oncogene

    (1999)
  • O.M. Conneely et al.

    Reproductive functions of progesterone receptors

    Recent Program of Hormonal Research

    (2002)
  • G.R. Cunha et al.

    Mammary phenotypic expression induced in epidermal cells by embryonic mammary mesenchyme

    Acta Anatomy

    (1995)
  • G.R. Cunha et al.

    Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants

    Journal Mammary Gland Biological Neoplasia

    (1997)
  • M. Cuny et al.

    Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations

    Cancer Research

    (2000)
  • C.V. Dang

    c-myc target genes involved in cell growth, apoptosis, and metabolism

    Molecular and Cellular Biology

    (1999)
  • J.E. Darnell

    Stats and gene regulation

    Science

    (1997)
  • C.M. D’Cruz et al.

    c-myc induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

    Natural Medicine

    (2001)
  • P.Y. Desprez et al.

    Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1

    Molecular and Cellular Biology

    (1995)
  • P.Y. Desprez et al.

    A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1

    Molecular and Cellular Biology

    (1998)
  • D. Dubik et al.

    Mechanism of estrogen activation of c-myc oncogene expression

    Oncogene

    (1992)
  • H.L. Ford et al.

    Abrogation of the G2 cell cycle checkpoint associated with overexpression of Hsix1: a possible mechanism of breast carcinogenesis

    Proceedings of the National Academy of Sciences of United States of America

    (1998)
  • J. Frasor et al.

    Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription

    Molecular Endocrinology

    (2001)
  • Y. Friedmann et al.

    Hox genes in normal and neoplastic mouse mammary gland

    Cancer Research

    (1994)
  • A. Garcia-Gasca et al.

    Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice

    Development Dynamics

    (2000)
  • R. Garcia et al.

    Constitutive activation of Stat3 by the SRC and Jak tyrosine kinases participates in growth regulation of human breast carcinoma cells

    Oncogene

    (2001)
  • B.J. Graves et al.

    Specificity within the Ets family of transcription factors

    Advanced Cancer Research

    (1998)
  • S. Gruvberger et al.

    Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns

    Cancer Research

    (2001)
  • L. Hennighausen et al.

    Think globally, act locally: the making of a mouse mammary gland

    Genes Development

    (1998)
  • T.C. He et al.

    Identification of c-myc as a target of the APC pathway

    Science

    (1998)
  • G. Hu et al.

    Msx homeobox genes inhibit differentiation through upregulation of cyclin D1

    Development

    (2001)
  • R.C. Humphreys et al.

    Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli

    Endocrinology

    (2002)
  • R.C. Humphreys et al.

    Mammary gland development is mediated by both stromal and epithelial progesterone receptors

    Molecular Endocrinology

    (1997)
  • N.E. Hynes et al.

    myc and mammary cancer: myc is a downstream effector of the ErbB2 receptor tyrosine kinase

    Journal Mammary Gland Biological Neoplasia

    (2001)
  • Cited by (0)

    View full text